Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micafungin + AmBisome for Invasive Aspergillosis
NCT00047827Phase 2Terminated
- Sponsor
- Astellas Pharma
- Start
- Dec 2002
- Primary completion
- Feb 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of micafungin in invasive aspergillosis (IA), sponsored by Astellas Pharma. Started Dec 2002; status: terminated.
02
Drugs
micafungin
03
Conditions
invasive aspergillosis (IA)
Beyond the preview
Go deeper on NCT00047827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00047827.